NMDP

We're proud to begin a new chapter in our life-saving work. We are NMDP. As a global leader in cell therapy, we believe each of us holds the key to curing blood cancers and disorders. Our organization has decades of life-saving work as the most diverse blood stem cell donor registry and as leading research and health care partners. Today, by uniting and simplifying our names, we show the breadth and depth of our abilities to advance cell therapy. Although our name has changed, our commitment to ensuring every patient can receive their life-saving therapy remains. NMDP. Find cures. Save lives. Discover more about our new unified identity 👉 https://bit.ly/3HvgSdn #NMDP #CellTherapy #SavingLives

If you're a patient or a caregiver, did you know our Peer Connect Program allows you to connect with someone who's been in your shoes? No matter where you are in the blood or marrow transplant (BMT) process, our trained volunteers—who have been patients or caregivers themselves—are ready to share their experiences and answer your questions. Discover more about this supportive community 👉 https://bit.ly/4bSZpbt #NMDP #BloodStemCellTransplant #Caregiving

Want to see what it means for good to go a long way? Check out a few things we accomplished in 2023: 💙 7,435 lives impacted through cell therapy (more than any other year since our founding!) 💙 330,000+ potential donors added to the NMDP Registry 💙 200 research studies and clinical trials in progress 💙 2,600 patient families financially supported through treatment 💙 $15.5 million raised by our supporters and contributors With the support of our incredible community, we pushed the boundaries of what’s possible. Read more about our work in 2023 👉 https://bit.ly/3zvbO7M #NMDP #GoodGoesALongWay #Fundraising

Trish was inspired to join the NMDP Registry after seeing a video of a patient who needed a match. Years later, she found out she was a match for another searching patient and eagerly agreed to donate. Next month, Trish will finally have the chance to meet her recipient, Noe, at our annual NMDP Gala in Los Angeles. “It’s one of the most rewarding feelings to save a stranger’s life. It matters even more. You are literally giving a piece of yourself, and they can survive. It is one of the most rewarding feelings ever.” -Trish Don't miss this heartwarming moment! Get your tickets now before they sell out 👉 https://bit.ly/45ZELVG #NMDP #GoodGoesALongWay #Fundraising

Since 1998, the NMDP Amy Strelzer Manasevit Research Program has supported 51 scholars and 12 post-doctoral fellows in researching life-saving solutions to post-transplant complications. As an Amy Scholar, you can join them in achieving breakthroughs that protect the health of cell therapy patients. Applications for this opportunity are open until Aug. 16—apply now and share with researchers in your network 👉 https://bit.ly/49zF1ve #NMDP #Research #CellTherapy

Step into a career that changes lives! As a Donor Engagement Specialist (Bilingual, Vietnamese), you'll follow in Caroline's footsteps, who excelled in this role and was recently promoted. You'll be the critical first point of contact with potential donors and guide them through the donation process. This position is crucial for educating Vietnamese-speaking donors, ensuring culturally appropriate support and enhancing our mission to save lives through cell therapy. If you're skilled at building rapport with others and enjoy a fast-paced work environment, this could be your #BestJobEver. Apply now or share with your network 👉 https://bit.ly/46cnV6d #NMDP #Communication #Career #Vietnamese #Bilingual

Practice-changing insights from our collaborative research program CIBMTR (Center for International Blood & Marrow Transplant Research)'s study published in the American Society of Clinical Oncology (ASCO)'s Journal of Clinical Oncology shows that patients receiving blood stem cell transplants from mismatched unrelated donors along with a novel drug called post-transplant cyclophosphamide (PTCy) can have similar outcomes to those with fully matched donors. Explore more from STAT about how these key findings could significantly widen the pool of suitable donors, expanding access to all patients regardless of ancestry 👉 https://bit.ly/4bXmda8 #NMDP #DonorForAll #Research #HealthEquity

If you're feeling overwhelmed by the blood stem cell transplant process, explore the support you deserve with our NMDP Patient and Caregiver Emotional Support (PACES) Program. The PACES Program offers free, one-on-one virtual support from an experienced social worker to help you and your loved ones manage the challenges of illness, treatment and recovery. Whether you need regular sessions, a check-in or assistance accessing local resources, our team is here to support you. Services are also offered in Spanish with our bilingual social worker 👉 https://bit.ly/4bMrdy7 #NMDP #BloodStemCellTransplant #Caregiving

Just wrapped at the #BestOfASCO: an insightful presentation of promising interim data from our ACCESS trial, conducted through our collaborative research program, CIBMTR (Center for International Blood & Marrow Transplant Research). Originally presented by City of Hope's Dr. Monzr Al Malki, the study highlights the potential of blood stem cell transplants using mismatched unrelated donors to expand access to transplants. Discover more about this transformative research and its impact on the future of transplantation 👉 https://bit.ly/4bSYV5X #NMDP #DonorForAll #Research #CellTherapy

The Best of ASCO is underway in Boston! Visit our very own Jason DeLeon and Kurt Biedermann at booth #3 to find out how our transformative research is making blood stem cell transplants accessible to more patients. Plus, don't miss tomorrow's session to hear more about the promising results from our ACCESS study using mismatched unrelated donors. Find the session details here 👉 https://bit.ly/4cVTTWZ #NMDP #BestOfASCO #DonorForAll #Research